Drug
ENV-294
ENV-294 is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
recruiting267%
not_yet_recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_2
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
NCT07301255
recruitingphase_2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07298395
not_yet_recruitingphase_2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07643766
Clinical Trials (3)
Showing 3 of 3 trials
NCT07301255Phase 2
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
NCT07298395Phase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07643766Phase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3